Olympus Corporation of the Americas recalls Uretero-reno videoscope URF-V2 and URF-V2R endoscope and accessories The URF-V2/V2R endoscopes are intended for use in…
- Recall date
- December 12, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1252-2017
- FDA classification
- Class II
- Brand / firm
- Olympus Corporation of the Americas
- Sold / distributed
- Worldwide distribution-US Nationwide and country of: Canada.
Why it was recalled
Olympus has received complaints regarding the breakage of the endoscope's insertion tube bending section during surgical procedures. Some of these complaints are associated with tissue trauma, including perforation, and insertion tubes which were stuck inside the patient and had to be surgically removed.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Uretero-reno videoscope URF-V2 and URF-V2R endoscope and accessories The URF-V2/V2R endoscopes are intended for use in endoscopic diagnosis and treatment within the ureter and kidney.
Get recall alerts
Free email alert whenever Olympus Corporation of the Americas has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Olympus Corporation of the Americas